https://blog.rackons.in/rss/author/kanishk-kumar Rackons & Free Classified Ad in India, Post Free ads , Sell Anything, Buy Anything & Kanishk Kumar en Copyright 2024 Rackons Blog & All Rights Reserved. https://blog.rackons.in/prurigo-nodularis-market-opportunities-for-investors https://blog.rackons.in/prurigo-nodularis-market-opportunities-for-investors Sun, 30 Nov 2025 12:36:35 +0530 Kanishk Kumar https://blog.rackons.in/sglt2-inhibitors-and-their-role-in-comprehensive-diabetes-care https://blog.rackons.in/sglt2-inhibitors-and-their-role-in-comprehensive-diabetes-care Sun, 26 Oct 2025 14:19:44 +0530 Kanishk Kumar https://blog.rackons.in/exosome-industry-report-market-trends-and-key-players https://blog.rackons.in/exosome-industry-report-market-trends-and-key-players Thu, 23 Oct 2025 15:28:23 +0530 Kanishk Kumar https://blog.rackons.in/iga-nephropathy-igan-market-analysis-trends-insights-and-forecasts-385245 https://blog.rackons.in/iga-nephropathy-igan-market-analysis-trends-insights-and-forecasts-385245 Thu, 23 Oct 2025 10:29:14 +0530 Kanishk Kumar https://blog.rackons.in/iga-nephropathy-igan-market-analysis-trends-insights-and-forecasts https://blog.rackons.in/iga-nephropathy-igan-market-analysis-trends-insights-and-forecasts Thu, 23 Oct 2025 10:27:40 +0530 Kanishk Kumar https://blog.rackons.in/besremi-market-insight-report-key-drivers-players-and-outlook-385170 https://blog.rackons.in/besremi-market-insight-report-key-drivers-players-and-outlook-385170 Wed, 22 Oct 2025 15:43:03 +0530 Kanishk Kumar https://blog.rackons.in/besremi-market-insight-report-key-drivers-players-and-outlook-385169 https://blog.rackons.in/besremi-market-insight-report-key-drivers-players-and-outlook-385169 Wed, 22 Oct 2025 15:42:38 +0530 Kanishk Kumar https://blog.rackons.in/besremi-market-insight-report-key-drivers-players-and-outlook https://blog.rackons.in/besremi-market-insight-report-key-drivers-players-and-outlook Wed, 22 Oct 2025 15:42:12 +0530 Kanishk Kumar https://blog.rackons.in/the-changing-landscape-of-heart-disease-treatment-with-pcsk9-inhibitors https://blog.rackons.in/the-changing-landscape-of-heart-disease-treatment-with-pcsk9-inhibitors Tue, 21 Oct 2025 21:23:58 +0530 Kanishk Kumar https://blog.rackons.in/cytokine-release-syndrome-market-trends-opportunities-and-forecast https://blog.rackons.in/cytokine-release-syndrome-market-trends-opportunities-and-forecast Tue, 21 Oct 2025 18:36:39 +0530 Kanishk Kumar https://blog.rackons.in/igg4-related-disease-market https://blog.rackons.in/igg4-related-disease-market Fri, 19 Sep 2025 13:06:04 +0530 Kanishk Kumar https://blog.rackons.in/updates-in-myelofibrosis-treatment-a-2024-review https://blog.rackons.in/updates-in-myelofibrosis-treatment-a-2024-review Thu, 18 Sep 2025 16:59:42 +0530 Kanishk Kumar https://blog.rackons.in/hashimotos-thyroiditis-market https://blog.rackons.in/hashimotos-thyroiditis-market Thu, 18 Sep 2025 13:36:01 +0530 Kanishk Kumar https://blog.rackons.in/malignant-pleural-mesothelioma-mpm-market https://blog.rackons.in/malignant-pleural-mesothelioma-mpm-market Wed, 17 Sep 2025 18:11:53 +0530 Kanishk Kumar https://blog.rackons.in/liver-fibrosis-market https://blog.rackons.in/liver-fibrosis-market Wed, 17 Sep 2025 17:26:17 +0530 Kanishk Kumar https://blog.rackons.in/innovation-in-pediatric-cancer-care-the-lutathera-approach https://blog.rackons.in/innovation-in-pediatric-cancer-care-the-lutathera-approach Tue, 16 Sep 2025 15:45:09 +0530 Kanishk Kumar https://blog.rackons.in/the-22-most-important-healthcare-innovations https://blog.rackons.in/the-22-most-important-healthcare-innovations Mon, 15 Sep 2025 21:47:03 +0530 Kanishk Kumar https://blog.rackons.in/nanomedicines-impact-on-healthcare-delivery-models https://blog.rackons.in/nanomedicines-impact-on-healthcare-delivery-models Sat, 13 Sep 2025 18:02:56 +0530 Kanishk Kumar https://blog.rackons.in/five-global-conditions-behind-the-highest-deaths https://blog.rackons.in/five-global-conditions-behind-the-highest-deaths Thu, 11 Sep 2025 16:26:49 +0530 Kanishk Kumar https://blog.rackons.in/bms-or-janssen-whos-better-positioned-in-myeloma https://blog.rackons.in/bms-or-janssen-whos-better-positioned-in-myeloma Wed, 10 Sep 2025 14:58:13 +0530 Kanishk Kumar https://blog.rackons.in/traumatic-brain-injury-tbi-treatment-market https://blog.rackons.in/traumatic-brain-injury-tbi-treatment-market Tue, 09 Sep 2025 11:57:58 +0530 Kanishk Kumar https://blog.rackons.in/ovarian-cancer-treatment-market-therapeutic-advances-372020 https://blog.rackons.in/ovarian-cancer-treatment-market-therapeutic-advances-372020 Mon, 08 Sep 2025 15:48:09 +0530 Kanishk Kumar https://blog.rackons.in/ovarian-cancer-treatment-market-therapeutic-advances-372019 https://blog.rackons.in/ovarian-cancer-treatment-market-therapeutic-advances-372019 Mon, 08 Sep 2025 15:47:19 +0530 Kanishk Kumar https://blog.rackons.in/ovarian-cancer-treatment-market-therapeutic-advances https://blog.rackons.in/ovarian-cancer-treatment-market-therapeutic-advances Mon, 08 Sep 2025 15:47:14 +0530 Kanishk Kumar https://blog.rackons.in/emerging-treatments-and-market-outlook-for-bone-marrow-failure https://blog.rackons.in/emerging-treatments-and-market-outlook-for-bone-marrow-failure Sun, 07 Sep 2025 17:56:25 +0530 Kanishk Kumar https://blog.rackons.in/lillys-zepbound-earns-fda-go-ahead-for-sleep-apnea-371785 https://blog.rackons.in/lillys-zepbound-earns-fda-go-ahead-for-sleep-apnea-371785 Sun, 07 Sep 2025 16:40:29 +0530 Kanishk Kumar https://blog.rackons.in/lillys-zepbound-earns-fda-go-ahead-for-sleep-apnea https://blog.rackons.in/lillys-zepbound-earns-fda-go-ahead-for-sleep-apnea Sun, 07 Sep 2025 16:37:24 +0530 Kanishk Kumar https://blog.rackons.in/mucopolysaccharidosis-i-mps-i-treatment-market https://blog.rackons.in/mucopolysaccharidosis-i-mps-i-treatment-market Sat, 06 Sep 2025 21:16:40 +0530 Kanishk Kumar https://blog.rackons.in/pheochromocytomas-and-paragangliomas-ppgl-treatment-market https://blog.rackons.in/pheochromocytomas-and-paragangliomas-ppgl-treatment-market Sat, 06 Sep 2025 15:11:17 +0530 Kanishk Kumar https://blog.rackons.in/transforming-protein-networks-into-treatments-with-molecular-glues-371323 https://blog.rackons.in/transforming-protein-networks-into-treatments-with-molecular-glues-371323 Thu, 04 Sep 2025 14:24:29 +0530 Kanishk Kumar https://blog.rackons.in/transforming-protein-networks-into-treatments-with-molecular-glues-371322 https://blog.rackons.in/transforming-protein-networks-into-treatments-with-molecular-glues-371322 Thu, 04 Sep 2025 14:23:28 +0530 Kanishk Kumar https://blog.rackons.in/transforming-protein-networks-into-treatments-with-molecular-glues-371319 https://blog.rackons.in/transforming-protein-networks-into-treatments-with-molecular-glues-371319 Thu, 04 Sep 2025 14:21:42 +0530 Kanishk Kumar https://blog.rackons.in/transforming-protein-networks-into-treatments-with-molecular-glues https://blog.rackons.in/transforming-protein-networks-into-treatments-with-molecular-glues Thu, 04 Sep 2025 14:20:31 +0530 Kanishk Kumar https://blog.rackons.in/understanding-the-peritoneal-carcinomatosis-market-current-and-future-perspectives-delveinsight https://blog.rackons.in/understanding-the-peritoneal-carcinomatosis-market-current-and-future-perspectives-delveinsight Thu, 04 Sep 2025 11:28:19 +0530 Kanishk Kumar https://blog.rackons.in/hashimotos-thyroiditis-therapeutics-market-size-share-and-forecast-by-2034-delveinsight https://blog.rackons.in/hashimotos-thyroiditis-therapeutics-market-size-share-and-forecast-by-2034-delveinsight Thu, 04 Sep 2025 10:15:37 +0530 Kanishk Kumar https://blog.rackons.in/advancing-patient-outcomes-through-data-science https://blog.rackons.in/advancing-patient-outcomes-through-data-science Wed, 03 Sep 2025 10:27:40 +0530 Kanishk Kumar https://blog.rackons.in/global-bone-densitometry-market-top-industry-leaders https://blog.rackons.in/global-bone-densitometry-market-top-industry-leaders Tue, 02 Sep 2025 10:51:52 +0530 Kanishk Kumar https://blog.rackons.in/triple-negative-breast-cancer-tnbc-market-therapeutic-advances https://blog.rackons.in/triple-negative-breast-cancer-tnbc-market-therapeutic-advances Mon, 01 Sep 2025 11:54:17 +0530 Kanishk Kumar https://blog.rackons.in/whats-changing-in-uveitis-treatment https://blog.rackons.in/whats-changing-in-uveitis-treatment Mon, 01 Sep 2025 11:40:20 +0530 Kanishk Kumar https://blog.rackons.in/growth-hormone-deficiency-ghd-treatment-market https://blog.rackons.in/growth-hormone-deficiency-ghd-treatment-market Sat, 30 Aug 2025 15:15:55 +0530 Kanishk Kumar https://blog.rackons.in/global-drug-industry-top-nations-ranked https://blog.rackons.in/global-drug-industry-top-nations-ranked Fri, 29 Aug 2025 19:01:51 +0530 Kanishk Kumar https://blog.rackons.in/follicular-lymphoma-therapeutics-market-current-landscape-and-future-outlook https://blog.rackons.in/follicular-lymphoma-therapeutics-market-current-landscape-and-future-outlook Thu, 28 Aug 2025 14:11:17 +0530 Kanishk Kumar https://blog.rackons.in/who-wins-the-weight-loss-race-eli-lilly-vs-novo-nordisk https://blog.rackons.in/who-wins-the-weight-loss-race-eli-lilly-vs-novo-nordisk Thu, 28 Aug 2025 13:21:36 +0530 Kanishk Kumar https://blog.rackons.in/understanding-the-spectrum-of-mps-disorders-for-better-care https://blog.rackons.in/understanding-the-spectrum-of-mps-disorders-for-better-care Wed, 27 Aug 2025 13:46:28 +0530 Kanishk Kumar https://blog.rackons.in/myelofibrosis-mf-treatment-market https://blog.rackons.in/myelofibrosis-mf-treatment-market Tue, 26 Aug 2025 15:02:33 +0530 Kanishk Kumar https://blog.rackons.in/the-12-most-expensive-medicines-you-can-buy-in-america https://blog.rackons.in/the-12-most-expensive-medicines-you-can-buy-in-america Tue, 26 Aug 2025 14:12:07 +0530 Kanishk Kumar https://blog.rackons.in/graft-versus-host-disease-gvhd-treatment-market https://blog.rackons.in/graft-versus-host-disease-gvhd-treatment-market Mon, 25 Aug 2025 15:35:58 +0530 Kanishk Kumar https://blog.rackons.in/smart-healthcare-devices-and-the-rise-of-remote-care https://blog.rackons.in/smart-healthcare-devices-and-the-rise-of-remote-care Mon, 25 Aug 2025 13:15:53 +0530 Kanishk Kumar https://blog.rackons.in/polycythemia-vera-pv-treatment-market https://blog.rackons.in/polycythemia-vera-pv-treatment-market Fri, 22 Aug 2025 15:30:12 +0530 Kanishk Kumar https://blog.rackons.in/non-small-cell-lung-cancer-nsclc-market-innovations-growth https://blog.rackons.in/non-small-cell-lung-cancer-nsclc-market-innovations-growth Fri, 22 Aug 2025 14:59:05 +0530 Kanishk Kumar https://blog.rackons.in/kidney-transplant-rejection-market-innovations-key-players https://blog.rackons.in/kidney-transplant-rejection-market-innovations-key-players Fri, 22 Aug 2025 13:49:30 +0530 Kanishk Kumar https://blog.rackons.in/preeclampsia-therapeutics-market-dynamics-and-innovations-366588 https://blog.rackons.in/preeclampsia-therapeutics-market-dynamics-and-innovations-366588 Fri, 22 Aug 2025 12:58:46 +0530 Kanishk Kumar https://blog.rackons.in/structural-inequality-as-a-predictor-of-covid-19-impact https://blog.rackons.in/structural-inequality-as-a-predictor-of-covid-19-impact Thu, 21 Aug 2025 16:53:12 +0530 Kanishk Kumar https://blog.rackons.in/femtechs-growing-impact-on-global-womens-healthcare https://blog.rackons.in/femtechs-growing-impact-on-global-womens-healthcare Thu, 21 Aug 2025 15:38:44 +0530 Kanishk Kumar https://blog.rackons.in/speech-tech-in-reducing-doctor-burnout https://blog.rackons.in/speech-tech-in-reducing-doctor-burnout Tue, 19 Aug 2025 11:44:00 +0530 Kanishk Kumar https://blog.rackons.in/innovative-drugs-and-their-impact-on-ulcerative-colitis-management https://blog.rackons.in/innovative-drugs-and-their-impact-on-ulcerative-colitis-management Tue, 19 Aug 2025 10:20:46 +0530 Kanishk Kumar https://blog.rackons.in/how-blockchain-enhances-healthcare-transparency https://blog.rackons.in/how-blockchain-enhances-healthcare-transparency Mon, 18 Aug 2025 14:24:58 +0530 Kanishk Kumar https://blog.rackons.in/multiple-system-atrophy-msa-market-insights https://blog.rackons.in/multiple-system-atrophy-msa-market-insights Sun, 10 Aug 2025 22:14:40 +0530 Kanishk Kumar https://blog.rackons.in/spinal-cord-injury-market-key-drivers-innovators https://blog.rackons.in/spinal-cord-injury-market-key-drivers-innovators Sun, 10 Aug 2025 21:18:21 +0530 Kanishk Kumar https://blog.rackons.in/no-strings-attached-the-brains-wireless-future https://blog.rackons.in/no-strings-attached-the-brains-wireless-future Sun, 10 Aug 2025 19:19:59 +0530 Kanishk Kumar https://blog.rackons.in/keloids-research-pipeline-clinical-studies-leading-companies-treatment-evaluation-novel-therapies-care-protocols-and-development-analysis-sirnaomics-yuhan-pharmaceuticals-lemonex-inc-cellionbiomed-362180 https://blog.rackons.in/keloids-research-pipeline-clinical-studies-leading-companies-treatment-evaluation-novel-therapies-care-protocols-and-development-analysis-sirnaomics-yuhan-pharmaceuticals-lemonex-inc-cellionbiomed-362180 Fri, 08 Aug 2025 10:36:22 +0530 Kanishk Kumar https://blog.rackons.in/complicated-skin-and-soft-tissue-infections-research-pipeline-clinical-studies-leading-companies-treatment-evaluation-novel-therapies-care-protocols-and-development-analysis-micurx-pharmaceuticals-inc-basilea-pharmaceutica-362170 https://blog.rackons.in/complicated-skin-and-soft-tissue-infections-research-pipeline-clinical-studies-leading-companies-treatment-evaluation-novel-therapies-care-protocols-and-development-analysis-micurx-pharmaceuticals-inc-basilea-pharmaceutica-362170 Fri, 08 Aug 2025 09:39:21 +0530 Kanishk Kumar https://blog.rackons.in/papulopustular-rosacea-research-pipeline-clinical-studies-leading-companies-treatment-evaluation-novel-therapies-care-protocols-and-development-analysis-timber-pharmaceuticals-dermata-therapeutics-cage-bio-promius-pharma-alfasigma-biomimetix-362164 https://blog.rackons.in/papulopustular-rosacea-research-pipeline-clinical-studies-leading-companies-treatment-evaluation-novel-therapies-care-protocols-and-development-analysis-timber-pharmaceuticals-dermata-therapeutics-cage-bio-promius-pharma-alfasigma-biomimetix-362164 Fri, 08 Aug 2025 09:10:42 +0530 Kanishk Kumar https://blog.rackons.in/papulopustular-rosacea-research-pipeline-clinical-studies-leading-companies-treatment-evaluation-novel-therapies-care-protocols-and-development-analysis-timber-pharmaceuticals-dermata-therapeutics-cage-bio-promius-pharma-alfasigma-biomimetix-362161 https://blog.rackons.in/papulopustular-rosacea-research-pipeline-clinical-studies-leading-companies-treatment-evaluation-novel-therapies-care-protocols-and-development-analysis-timber-pharmaceuticals-dermata-therapeutics-cage-bio-promius-pharma-alfasigma-biomimetix-362161 Fri, 08 Aug 2025 08:44:19 +0530 Kanishk Kumar https://blog.rackons.in/7-disruptive-forces-reshaping-femtechs-future https://blog.rackons.in/7-disruptive-forces-reshaping-femtechs-future Thu, 07 Aug 2025 17:24:46 +0530 Kanishk Kumar https://blog.rackons.in/regal-risk-a-dynasty-tainted-by-hemophilia https://blog.rackons.in/regal-risk-a-dynasty-tainted-by-hemophilia Thu, 07 Aug 2025 15:21:51 +0530 Kanishk Kumar https://blog.rackons.in/tryviojeraygo-strategic-market-insights-and-long-term-forecast https://blog.rackons.in/tryviojeraygo-strategic-market-insights-and-long-term-forecast Wed, 06 Aug 2025 17:55:48 +0530 Kanishk Kumar https://blog.rackons.in/keytruda-or-opdivo-who-dominates-japans-pd-1-scene https://blog.rackons.in/keytruda-or-opdivo-who-dominates-japans-pd-1-scene Mon, 04 Aug 2025 15:46:30 +0530 Kanishk Kumar https://blog.rackons.in/opdivo-and-keytruda-in-japan-market-rivals-in-immuno-oncology https://blog.rackons.in/opdivo-and-keytruda-in-japan-market-rivals-in-immuno-oncology Mon, 04 Aug 2025 14:52:13 +0530 Kanishk Kumar https://blog.rackons.in/navigating-the-brain-imaging-devices-market-strategy-and-insight https://blog.rackons.in/navigating-the-brain-imaging-devices-market-strategy-and-insight Mon, 04 Aug 2025 10:25:43 +0530 Kanishk Kumar https://blog.rackons.in/market-snapshot-elafibranors-development-status-and-future-projections https://blog.rackons.in/market-snapshot-elafibranors-development-status-and-future-projections Sun, 03 Aug 2025 23:19:08 +0530 Kanishk Kumar https://blog.rackons.in/rising-demand-in-cancer-immunotherapy-and-autoimmune-research-drives-il-2-market-growth https://blog.rackons.in/rising-demand-in-cancer-immunotherapy-and-autoimmune-research-drives-il-2-market-growth Sun, 03 Aug 2025 20:09:05 +0530 Kanishk Kumar https://blog.rackons.in/keloids-research-pipeline-clinical-studies-leading-companies-treatment-evaluation-novel-therapies-care-protocols-and-development-analysis-sirnaomics-yuhan-pharmaceuticals-lemonex-inc-cellionbiomed https://blog.rackons.in/keloids-research-pipeline-clinical-studies-leading-companies-treatment-evaluation-novel-therapies-care-protocols-and-development-analysis-sirnaomics-yuhan-pharmaceuticals-lemonex-inc-cellionbiomed Fri, 01 Aug 2025 16:05:05 +0530 Kanishk Kumar https://blog.rackons.in/chronic-induced-urticaria-research-pipeline-clinical-studies-key-players-treatment-evaluation-novel-therapies-care-protocols-development-analysis-celldex-therapeutics-jasper-therapeutics https://blog.rackons.in/chronic-induced-urticaria-research-pipeline-clinical-studies-key-players-treatment-evaluation-novel-therapies-care-protocols-development-analysis-celldex-therapeutics-jasper-therapeutics Wed, 30 Jul 2025 19:41:55 +0530 Kanishk Kumar https://blog.rackons.in/enhertus-dual-impact-clinical-success-and-market-growth https://blog.rackons.in/enhertus-dual-impact-clinical-success-and-market-growth Mon, 28 Jul 2025 17:29:48 +0530 Kanishk Kumar https://blog.rackons.in/complicated-skin-and-soft-tissue-infections-research-pipeline-clinical-studies-leading-companies-treatment-evaluation-novel-therapies-care-protocols-and-development-analysis-micurx-pharmaceuticals-inc-basilea-pharmaceutica https://blog.rackons.in/complicated-skin-and-soft-tissue-infections-research-pipeline-clinical-studies-leading-companies-treatment-evaluation-novel-therapies-care-protocols-and-development-analysis-micurx-pharmaceuticals-inc-basilea-pharmaceutica Mon, 28 Jul 2025 11:48:41 +0530 Kanishk Kumar https://blog.rackons.in/thymidine-kinase-2-deficiency-tk2d-357441 https://blog.rackons.in/thymidine-kinase-2-deficiency-tk2d-357441 Sun, 27 Jul 2025 19:28:26 +0530 Kanishk Kumar https://blog.rackons.in/thymidine-kinase-2-deficiency-tk2d https://blog.rackons.in/thymidine-kinase-2-deficiency-tk2d Sun, 27 Jul 2025 19:28:21 +0530 Kanishk Kumar https://blog.rackons.in/papulopustular-rosacea-research-pipeline-clinical-studies-leading-companies-treatment-evaluation-novel-therapies-care-protocols-and-development-analysis-timber-pharmaceuticals-dermata-therapeutics-cage-bio-promius-pharma-alfasigma-biomimetix https://blog.rackons.in/papulopustular-rosacea-research-pipeline-clinical-studies-leading-companies-treatment-evaluation-novel-therapies-care-protocols-and-development-analysis-timber-pharmaceuticals-dermata-therapeutics-cage-bio-promius-pharma-alfasigma-biomimetix Sun, 27 Jul 2025 18:08:50 +0530 Kanishk Kumar https://blog.rackons.in/varicose-ulcer-research-pipeline-clinical-studies-leading-companies-treatment-evaluation-novel-therapies-care-protocols-and-development-analysis-mediwound-ltd-xinnate-ab https://blog.rackons.in/varicose-ulcer-research-pipeline-clinical-studies-leading-companies-treatment-evaluation-novel-therapies-care-protocols-and-development-analysis-mediwound-ltd-xinnate-ab Sun, 27 Jul 2025 17:26:33 +0530 Kanishk Kumar https://blog.rackons.in/the-top-7-biotech-names-advancing-trispecific-antibody-science https://blog.rackons.in/the-top-7-biotech-names-advancing-trispecific-antibody-science Fri, 25 Jul 2025 15:14:47 +0530 Kanishk Kumar https://blog.rackons.in/vaginal-and-vulval-inflammatory-conditions-market-intelligence-by-delveinsight https://blog.rackons.in/vaginal-and-vulval-inflammatory-conditions-market-intelligence-by-delveinsight Thu, 24 Jul 2025 16:44:49 +0530 Kanishk Kumar https://blog.rackons.in/key-market-developments-in-cardiopulmonary-autotransfusion-delveinsight-insights https://blog.rackons.in/key-market-developments-in-cardiopulmonary-autotransfusion-delveinsight-insights Thu, 24 Jul 2025 13:31:44 +0530 Kanishk Kumar https://blog.rackons.in/mouth-neoplasms-market-insights-emerging-therapies-and-forecasts-356016 https://blog.rackons.in/mouth-neoplasms-market-insights-emerging-therapies-and-forecasts-356016 Wed, 23 Jul 2025 13:40:32 +0530 Kanishk Kumar https://blog.rackons.in/mouth-neoplasms-market-insights-emerging-therapies-and-forecasts https://blog.rackons.in/mouth-neoplasms-market-insights-emerging-therapies-and-forecasts Wed, 23 Jul 2025 13:40:09 +0530 Kanishk Kumar https://blog.rackons.in/herpes-simplex-treatment-market-forecast-a-deep-dive-with-delveinsight https://blog.rackons.in/herpes-simplex-treatment-market-forecast-a-deep-dive-with-delveinsight Wed, 23 Jul 2025 11:06:58 +0530 Kanishk Kumar https://blog.rackons.in/unlocking-potential-emerging-trends-in-gene-therapy-market https://blog.rackons.in/unlocking-potential-emerging-trends-in-gene-therapy-market Mon, 21 Jul 2025 19:31:55 +0530 Kanishk Kumar https://blog.rackons.in/mild-to-moderate-plaque-psoriasis-market-comprehensive-epidemiological-analysis-pipeline-assessment-and-leading-industry-players-abbvie-pfizer-johnson-johnson-jj-bristol-myers-squibb-ucb-pharma-amgen-novartis-eli-lilly-sun-pharma-dermavant-355110 https://blog.rackons.in/mild-to-moderate-plaque-psoriasis-market-comprehensive-epidemiological-analysis-pipeline-assessment-and-leading-industry-players-abbvie-pfizer-johnson-johnson-jj-bristol-myers-squibb-ucb-pharma-amgen-novartis-eli-lilly-sun-pharma-dermavant-355110 Mon, 21 Jul 2025 12:37:14 +0530 Kanishk Kumar https://blog.rackons.in/key-drivers-fueling-the-carpal-tunnel-release-market-boom https://blog.rackons.in/key-drivers-fueling-the-carpal-tunnel-release-market-boom Fri, 18 Jul 2025 17:56:34 +0530 Kanishk Kumar https://blog.rackons.in/moderate-to-severe-inflammatory-acne-vulgaris-comprehensive-pipeline-analysis-clinical-studies-leading-companies-therapeutic-evaluation-novel-treatments-and-development-insights-sagimet-biosciences-boston-pharmaceuticals-shanghai-fudan-zhangjiang https://blog.rackons.in/moderate-to-severe-inflammatory-acne-vulgaris-comprehensive-pipeline-analysis-clinical-studies-leading-companies-therapeutic-evaluation-novel-treatments-and-development-insights-sagimet-biosciences-boston-pharmaceuticals-shanghai-fudan-zhangjiang Fri, 18 Jul 2025 13:13:38 +0530 Kanishk Kumar https://blog.rackons.in/moderate-to-severe-atopic-dermatitis-clinical-research-and-non-clinical-investigations-leading-industry-players-treatment-evaluation-novel-therapeutic-approaches-management-protocols-and-development-pipeline-analysis-jiangsu-vcare-pharmaceutical-technology-co-ltd-shanghai-chia-tai-tianqing-ph-353787 https://blog.rackons.in/moderate-to-severe-atopic-dermatitis-clinical-research-and-non-clinical-investigations-leading-industry-players-treatment-evaluation-novel-therapeutic-approaches-management-protocols-and-development-pipeline-analysis-jiangsu-vcare-pharmaceutical-technology-co-ltd-shanghai-chia-tai-tianqing-ph-353787 Thu, 17 Jul 2025 13:48:15 +0530 Kanishk Kumar https://blog.rackons.in/moderate-to-severe-atopic-dermatitis-clinical-research-and-non-clinical-investigations-leading-industry-players-treatment-evaluation-novel-therapeutic-approaches-management-protocols-and-development-pipeline-analysis-jiangsu-vcare-pharmaceutical-technology-co-ltd-shanghai-chia-tai-tianqing-ph https://blog.rackons.in/moderate-to-severe-atopic-dermatitis-clinical-research-and-non-clinical-investigations-leading-industry-players-treatment-evaluation-novel-therapeutic-approaches-management-protocols-and-development-pipeline-analysis-jiangsu-vcare-pharmaceutical-technology-co-ltd-shanghai-chia-tai-tianqing-ph Thu, 17 Jul 2025 13:48:11 +0530 Kanishk Kumar https://blog.rackons.in/palmoplantar-keratoderma-drug-development-pipeline-clinical-research-key-industry-players-treatment-evaluation-novel-therapeutics-management-protocols-and-development-analysis-sol-gel-technologies-ltd-krystal-biotech-inc https://blog.rackons.in/palmoplantar-keratoderma-drug-development-pipeline-clinical-research-key-industry-players-treatment-evaluation-novel-therapeutics-management-protocols-and-development-analysis-sol-gel-technologies-ltd-krystal-biotech-inc Wed, 16 Jul 2025 13:37:17 +0530 Kanishk Kumar https://blog.rackons.in/delveinsight-provides-in-depth-insights-into-the-wet-amd-market https://blog.rackons.in/delveinsight-provides-in-depth-insights-into-the-wet-amd-market Tue, 15 Jul 2025 18:51:27 +0530 Kanishk Kumar https://blog.rackons.in/mild-to-moderate-plaque-psoriasis-market-comprehensive-epidemiological-analysis-pipeline-assessment-and-leading-industry-players-abbvie-pfizer-johnson-johnson-jj-bristol-myers-squibb-ucb-pharma-amgen-novartis-eli-lilly-sun-pharma-dermavant https://blog.rackons.in/mild-to-moderate-plaque-psoriasis-market-comprehensive-epidemiological-analysis-pipeline-assessment-and-leading-industry-players-abbvie-pfizer-johnson-johnson-jj-bristol-myers-squibb-ucb-pharma-amgen-novartis-eli-lilly-sun-pharma-dermavant Tue, 15 Jul 2025 13:36:37 +0530 Kanishk Kumar https://blog.rackons.in/therapeutic-developments-in-pnh-a-global-market-perspective https://blog.rackons.in/therapeutic-developments-in-pnh-a-global-market-perspective Mon, 14 Jul 2025 14:41:59 +0530 Kanishk Kumar https://blog.rackons.in/chronic-wounds-comprehensive-clinical-and-non-clinical-research-leading-companies-therapeutic-evaluation-novel-treatment-approaches-management-protocols-and-pipeline-intelligence-polarityte-aurealis-therapeutics-akribes-biomedical https://blog.rackons.in/chronic-wounds-comprehensive-clinical-and-non-clinical-research-leading-companies-therapeutic-evaluation-novel-treatment-approaches-management-protocols-and-pipeline-intelligence-polarityte-aurealis-therapeutics-akribes-biomedical Mon, 14 Jul 2025 13:10:06 +0530 Kanishk Kumar https://blog.rackons.in/intra-tumoral-cancer-therapies-fueling-the-next-wave-of-targeted-oncology https://blog.rackons.in/intra-tumoral-cancer-therapies-fueling-the-next-wave-of-targeted-oncology Fri, 11 Jul 2025 18:45:00 +0530 Kanishk Kumar https://blog.rackons.in/delveinsight-reviews-the-hepatitis-b-virus-market-growth-drivers https://blog.rackons.in/delveinsight-reviews-the-hepatitis-b-virus-market-growth-drivers Fri, 11 Jul 2025 16:04:53 +0530 Kanishk Kumar https://blog.rackons.in/epidermolysis-bullosa-pipeline-analysis-2025-comprehensive-treatment-development-landscape https://blog.rackons.in/epidermolysis-bullosa-pipeline-analysis-2025-comprehensive-treatment-development-landscape Fri, 11 Jul 2025 14:55:21 +0530 Kanishk Kumar https://blog.rackons.in/invasive-candidiasis-market-set-for-remarkable-expansion-through-2032-according-to-delveinsight-analysis https://blog.rackons.in/invasive-candidiasis-market-set-for-remarkable-expansion-through-2032-according-to-delveinsight-analysis Thu, 10 Jul 2025 18:03:53 +0530 Kanishk Kumar https://blog.rackons.in/breaking-down-the-non-cf-bronchiectasis-market-by-treatment-trends-and-forecasts https://blog.rackons.in/breaking-down-the-non-cf-bronchiectasis-market-by-treatment-trends-and-forecasts Thu, 10 Jul 2025 14:30:34 +0530 Kanishk Kumar https://blog.rackons.in/peanut-allergy-market-evolution-from-research-to-commercial-success https://blog.rackons.in/peanut-allergy-market-evolution-from-research-to-commercial-success Thu, 10 Jul 2025 11:55:02 +0530 Kanishk Kumar https://blog.rackons.in/transforming-fatty-liver-care-madrigals-rezdiffra-at-the-helm https://blog.rackons.in/transforming-fatty-liver-care-madrigals-rezdiffra-at-the-helm Wed, 09 Jul 2025 15:28:51 +0530 Kanishk Kumar https://blog.rackons.in/invasive-candidiasis-market-set-for-remarkable-expansion-through-2032-according-to-delveinsight-analysisinvasive-candidiasis-market-set-for-remarkable-expansion-through-2032-according-to-delveinsight-analysis https://blog.rackons.in/invasive-candidiasis-market-set-for-remarkable-expansion-through-2032-according-to-delveinsight-analysisinvasive-candidiasis-market-set-for-remarkable-expansion-through-2032-according-to-delveinsight-analysis Wed, 09 Jul 2025 13:16:34 +0530 Kanishk Kumar https://blog.rackons.in/next-gen-diagnosis-biomarkers-disentangling-bipolar-and-schizophrenic-symptoms https://blog.rackons.in/next-gen-diagnosis-biomarkers-disentangling-bipolar-and-schizophrenic-symptoms Tue, 08 Jul 2025 17:53:20 +0530 Kanishk Kumar https://blog.rackons.in/pushing-boundaries-in-uveitis-treatment-and-innovation https://blog.rackons.in/pushing-boundaries-in-uveitis-treatment-and-innovation Tue, 08 Jul 2025 15:49:17 +0530 Kanishk Kumar https://blog.rackons.in/drug-eruptions-market-positioned-for-sustained-growth-through-2032-delveinsight-analysis-reveals-350671 https://blog.rackons.in/drug-eruptions-market-positioned-for-sustained-growth-through-2032-delveinsight-analysis-reveals-350671 Tue, 08 Jul 2025 13:27:20 +0530 Kanishk Kumar https://blog.rackons.in/drug-eruptions-market-positioned-for-sustained-growth-through-2032-delveinsight-analysis-reveals-350670 https://blog.rackons.in/drug-eruptions-market-positioned-for-sustained-growth-through-2032-delveinsight-analysis-reveals-350670 Tue, 08 Jul 2025 13:27:15 +0530 Kanishk Kumar https://blog.rackons.in/drug-eruptions-market-positioned-for-sustained-growth-through-2032-delveinsight-analysis-reveals https://blog.rackons.in/drug-eruptions-market-positioned-for-sustained-growth-through-2032-delveinsight-analysis-reveals Tue, 08 Jul 2025 13:26:54 +0530 Kanishk Kumar https://blog.rackons.in/from-open-surgery-to-hd-vision-the-rise-of-surgical-imaging-tools https://blog.rackons.in/from-open-surgery-to-hd-vision-the-rise-of-surgical-imaging-tools Mon, 07 Jul 2025 18:23:54 +0530 Kanishk Kumar https://blog.rackons.in/hpv16-positive-hnscc-market-forecast-2034-a-delveinsight-outlook https://blog.rackons.in/hpv16-positive-hnscc-market-forecast-2034-a-delveinsight-outlook Mon, 07 Jul 2025 16:20:46 +0530 Kanishk Kumar https://blog.rackons.in/the-road-ahead-for-the-in-vitro-diagnostics-industry https://blog.rackons.in/the-road-ahead-for-the-in-vitro-diagnostics-industry Sun, 06 Jul 2025 19:30:53 +0530 Kanishk Kumar https://blog.rackons.in/emerging-therapies-and-market-shifts-in-nonmelanoma-skin-cancer https://blog.rackons.in/emerging-therapies-and-market-shifts-in-nonmelanoma-skin-cancer Fri, 04 Jul 2025 16:52:49 +0530 Kanishk Kumar https://blog.rackons.in/robotic-process-automation-use-cases-that-are-driving-healthcare-innovation https://blog.rackons.in/robotic-process-automation-use-cases-that-are-driving-healthcare-innovation Fri, 04 Jul 2025 09:44:54 +0530 Kanishk Kumar https://blog.rackons.in/cardiac-devices-leading-the-charge-against-cardiovascular-disease https://blog.rackons.in/cardiac-devices-leading-the-charge-against-cardiovascular-disease Thu, 03 Jul 2025 12:43:44 +0530 Kanishk Kumar https://blog.rackons.in/wearable-seizure-devices-empowering-epilepsy-patients https://blog.rackons.in/wearable-seizure-devices-empowering-epilepsy-patients Thu, 03 Jul 2025 10:26:27 +0530 Kanishk Kumar https://blog.rackons.in/duchenne-muscular-dystrophy-market-forecast-insights-from-delveinsight-349354 https://blog.rackons.in/duchenne-muscular-dystrophy-market-forecast-insights-from-delveinsight-349354 Wed, 02 Jul 2025 17:55:54 +0530 Kanishk Kumar https://blog.rackons.in/duchenne-muscular-dystrophy-market-forecast-insights-from-delveinsight https://blog.rackons.in/duchenne-muscular-dystrophy-market-forecast-insights-from-delveinsight Wed, 02 Jul 2025 17:55:52 +0530 Kanishk Kumar https://blog.rackons.in/investigating-the-acute-kidney-injury-market-current-scope-and-pipeline-advances https://blog.rackons.in/investigating-the-acute-kidney-injury-market-current-scope-and-pipeline-advances Wed, 02 Jul 2025 12:03:41 +0530 Kanishk Kumar https://blog.rackons.in/market-intelligence-on-postpartum-depression-2034-forecast-by-delveinsight https://blog.rackons.in/market-intelligence-on-postpartum-depression-2034-forecast-by-delveinsight Tue, 01 Jul 2025 18:06:06 +0530 Kanishk Kumar https://blog.rackons.in/growth-projections-in-enzyme-inhibitors-market-by-delveinsight https://blog.rackons.in/growth-projections-in-enzyme-inhibitors-market-by-delveinsight Tue, 01 Jul 2025 16:16:16 +0530 Kanishk Kumar https://blog.rackons.in/remote-care-revolution-digital-tools-for-chronic-health-needs https://blog.rackons.in/remote-care-revolution-digital-tools-for-chronic-health-needs Mon, 30 Jun 2025 17:54:13 +0530 Kanishk Kumar https://blog.rackons.in/eczema-treatment-market-2032-comprehensive-clinical-analysis-regulatory-approvals-market-dynamics-and-industry-insights-by-delveinsight https://blog.rackons.in/eczema-treatment-market-2032-comprehensive-clinical-analysis-regulatory-approvals-market-dynamics-and-industry-insights-by-delveinsight Sat, 28 Jun 2025 20:00:21 +0530 Kanishk Kumar https://blog.rackons.in/common-warts-treatment-market-analysis-through-2034-comprehensive-clinical-trial-updates-regulatory-approvals-market-revenue-and-industry-statistics-by-delveinsight https://blog.rackons.in/common-warts-treatment-market-analysis-through-2034-comprehensive-clinical-trial-updates-regulatory-approvals-market-revenue-and-industry-statistics-by-delveinsight Sat, 28 Jun 2025 19:10:19 +0530 Kanishk Kumar https://blog.rackons.in/ichthyosis-market-poised-for-substantial-expansion-through-2032-reports-delveinsight-leading-players-include-timber-pharma-krystal-biotech-gsk-and-janssen-scientific https://blog.rackons.in/ichthyosis-market-poised-for-substantial-expansion-through-2032-reports-delveinsight-leading-players-include-timber-pharma-krystal-biotech-gsk-and-janssen-scientific Sat, 28 Jun 2025 18:42:43 +0530 Kanishk Kumar https://blog.rackons.in/axillary-hyperhidrosis-market-growth-outlook-20232032-key-insights-by-delveinsight-featuring-botanix-pharma-dermata-therapeutics-abbvie-candesant-biomedical-and-more https://blog.rackons.in/axillary-hyperhidrosis-market-growth-outlook-20232032-key-insights-by-delveinsight-featuring-botanix-pharma-dermata-therapeutics-abbvie-candesant-biomedical-and-more Sat, 28 Jun 2025 18:08:21 +0530 Kanishk Kumar https://blog.rackons.in/actinic-keratosis-market-forecast-2034-comprehensive-regulatory-analysis-clinical-trials-prevalence-data-treatment-innovations-and-industry-intelligence-by-delveinsight https://blog.rackons.in/actinic-keratosis-market-forecast-2034-comprehensive-regulatory-analysis-clinical-trials-prevalence-data-treatment-innovations-and-industry-intelligence-by-delveinsight Tue, 24 Jun 2025 23:10:26 +0530 Kanishk Kumar https://blog.rackons.in/septic-arthritis-market-current-landscape-innovations-and-future-prospects https://blog.rackons.in/septic-arthritis-market-current-landscape-innovations-and-future-prospects Tue, 24 Jun 2025 09:54:53 +0530 Kanishk Kumar https://blog.rackons.in/chronic-hand-eczema-treatment-market-analysis-2034-comprehensive-clinical-insights-regulatory-landscape https://blog.rackons.in/chronic-hand-eczema-treatment-market-analysis-2034-comprehensive-clinical-insights-regulatory-landscape Fri, 20 Jun 2025 13:30:08 +0530 Kanishk Kumar https://blog.rackons.in/ulcerated-necrobiosis-lipoidica-market-analysis-significant-growth-expected-by-2034 https://blog.rackons.in/ulcerated-necrobiosis-lipoidica-market-analysis-significant-growth-expected-by-2034 Fri, 20 Jun 2025 13:01:39 +0530 Kanishk Kumar https://blog.rackons.in/pruritus-medication-market-to-2034-regulatory-approvals-ema-pdma-fda-clinical-studies-nda-approvals-pharmacotherapy-incidence-mechanism-of-action-financial-performance-data-analysis-industry-players-delveinsight-analysis-345222 https://blog.rackons.in/pruritus-medication-market-to-2034-regulatory-approvals-ema-pdma-fda-clinical-studies-nda-approvals-pharmacotherapy-incidence-mechanism-of-action-financial-performance-data-analysis-industry-players-delveinsight-analysis-345222 Fri, 20 Jun 2025 12:31:12 +0530 Kanishk Kumar https://blog.rackons.in/psoriasis-vulgaris-drugs-market-to-2032-clinical-studies-regulatory-approvals-ema-pdma-fda-drug-market-incidence-pharmacotherapy-data-analysis-treatment-options-industry-players-delveinsight-report https://blog.rackons.in/psoriasis-vulgaris-drugs-market-to-2032-clinical-studies-regulatory-approvals-ema-pdma-fda-drug-market-incidence-pharmacotherapy-data-analysis-treatment-options-industry-players-delveinsight-report Thu, 19 Jun 2025 12:02:02 +0530 Kanishk Kumar https://blog.rackons.in/pruritus-medication-market-to-2034-regulatory-approvals-ema-pdma-fda-clinical-studies-nda-approvals-pharmacotherapy-incidence-mechanism-of-action-financial-performance-data-analysis-industry-players-delveinsight-analysis https://blog.rackons.in/pruritus-medication-market-to-2034-regulatory-approvals-ema-pdma-fda-clinical-studies-nda-approvals-pharmacotherapy-incidence-mechanism-of-action-financial-performance-data-analysis-industry-players-delveinsight-analysis Wed, 18 Jun 2025 20:19:47 +0530 Kanishk Kumar https://blog.rackons.in/onycholysis-market-aims-for-robust-growth-by-2032-key-players-include-pfizer-etc-343976 https://blog.rackons.in/onycholysis-market-aims-for-robust-growth-by-2032-key-players-include-pfizer-etc-343976 Sun, 15 Jun 2025 22:14:35 +0530 Kanishk Kumar https://blog.rackons.in/pemphigus-vulgaris-drug-market-outlook-2034-approvals-clinical-status-epidemiology-nda-status-revenue-mechanism-of-action-leading-therapies-and-key-players-delveinsight-report-343092 https://blog.rackons.in/pemphigus-vulgaris-drug-market-outlook-2034-approvals-clinical-status-epidemiology-nda-status-revenue-mechanism-of-action-leading-therapies-and-key-players-delveinsight-report-343092 Wed, 11 Jun 2025 15:31:54 +0530 Kanishk Kumar https://blog.rackons.in/delveinsight-pressure-ulcer-treatment-market-2032-clinical-trials-regulatory-approvals-market-trends-and-emerging-therapies-342588 https://blog.rackons.in/delveinsight-pressure-ulcer-treatment-market-2032-clinical-trials-regulatory-approvals-market-trends-and-emerging-therapies-342588 Mon, 09 Jun 2025 17:31:49 +0530 Kanishk Kumar https://blog.rackons.in/extended-depth-of-focus-iols-a-new-standard-in-vision-correction https://blog.rackons.in/extended-depth-of-focus-iols-a-new-standard-in-vision-correction Fri, 06 Jun 2025 22:37:16 +0530 Kanishk Kumar https://blog.rackons.in/intelligent-healthcare-the-promise-of-artificial-intelligence https://blog.rackons.in/intelligent-healthcare-the-promise-of-artificial-intelligence Fri, 06 Jun 2025 14:03:55 +0530 Kanishk Kumar https://blog.rackons.in/atopic-dermatitis-drugs-market-forecast-to-2034-clinical-trials-regulatory-approvals-ema-pdma-fda-drugs-patient-insights-mechanism-of-action-moa-route-of-administration-roa-and-key-players-delveinsight https://blog.rackons.in/atopic-dermatitis-drugs-market-forecast-to-2034-clinical-trials-regulatory-approvals-ema-pdma-fda-drugs-patient-insights-mechanism-of-action-moa-route-of-administration-roa-and-key-players-delveinsight Thu, 05 Jun 2025 18:53:03 +0530 Kanishk Kumar https://blog.rackons.in/necrobiosis-lipodica-diabetes-market-is-expected-to-witness-significant-growth-from-2023-to-2032-according-to-delveinsight-process-pharmaceuticals https://blog.rackons.in/necrobiosis-lipodica-diabetes-market-is-expected-to-witness-significant-growth-from-2023-to-2032-according-to-delveinsight-process-pharmaceuticals Wed, 04 Jun 2025 17:57:48 +0530 Kanishk Kumar https://blog.rackons.in/delveinsight-pressure-ulcer-treatment-market-2032-clinical-trials-regulatory-approvals-market-trends-and-emerging-therapies https://blog.rackons.in/delveinsight-pressure-ulcer-treatment-market-2032-clinical-trials-regulatory-approvals-market-trends-and-emerging-therapies Mon, 02 Jun 2025 18:01:33 +0530 Kanishk Kumar https://blog.rackons.in/postherpetic-neuralgia-and-its-societal-burden-in-the-united-states https://blog.rackons.in/postherpetic-neuralgia-and-its-societal-burden-in-the-united-states Mon, 02 Jun 2025 09:44:48 +0530 Kanishk Kumar https://blog.rackons.in/innovative-approaches-to-hypophosphatasia-research-and-care https://blog.rackons.in/innovative-approaches-to-hypophosphatasia-research-and-care Sun, 01 Jun 2025 21:47:30 +0530 Kanishk Kumar https://blog.rackons.in/skin-burn-treatment-market-2034-clinical-trials-regulatory-approvals-market-trends-and-emerging-therapies-by-delveinsight https://blog.rackons.in/skin-burn-treatment-market-2034-clinical-trials-regulatory-approvals-market-trends-and-emerging-therapies-by-delveinsight Fri, 30 May 2025 10:22:09 +0530 Kanishk Kumar https://blog.rackons.in/the-economics-of-multiple-myeloma-treatment-market-impact-and-cost-challenges https://blog.rackons.in/the-economics-of-multiple-myeloma-treatment-market-impact-and-cost-challenges Wed, 28 May 2025 23:21:08 +0530 Kanishk Kumar https://blog.rackons.in/according-to-delveinsight-analysis-the-dystrophic-epidermolysis-bullosa-market-is-expected-to-witness-significant-growth-between-2024-and-2034-major-players-include-krystal-biotech-chiesi-phoenix-therapeutics-aegle-therapeutics-anterogen-and-others https://blog.rackons.in/according-to-delveinsight-analysis-the-dystrophic-epidermolysis-bullosa-market-is-expected-to-witness-significant-growth-between-2024-and-2034-major-players-include-krystal-biotech-chiesi-phoenix-therapeutics-aegle-therapeutics-anterogen-and-others Wed, 28 May 2025 18:33:12 +0530 Kanishk Kumar https://blog.rackons.in/acne-vulgaris-market-forecast-to-2034-regulatory-approvals-disease-prevalence-clinical-research-treatment-options-key-industry-players-delveinsight-analysis https://blog.rackons.in/acne-vulgaris-market-forecast-to-2034-regulatory-approvals-disease-prevalence-clinical-research-treatment-options-key-industry-players-delveinsight-analysis Tue, 27 May 2025 10:24:52 +0530 Kanishk Kumar https://blog.rackons.in/prurigo-nodularis-treatment-market-outlook-2034-clinical-trials-regulatory-approvals-fda-ema-pdma-emerging-therapies-epidemiology-moa-market-revenue-leading-companies-insights https://blog.rackons.in/prurigo-nodularis-treatment-market-outlook-2034-clinical-trials-regulatory-approvals-fda-ema-pdma-emerging-therapies-epidemiology-moa-market-revenue-leading-companies-insights Mon, 26 May 2025 09:29:44 +0530 Kanishk Kumar https://blog.rackons.in/chronic-urticaria-treatment-market-2032-clinical-trials-regulatory-status-fda-ema-pdma-drug-market-dynamics-prevalence-pipeline-treatments-key-statistics-key-players-delveinsight https://blog.rackons.in/chronic-urticaria-treatment-market-2032-clinical-trials-regulatory-status-fda-ema-pdma-drug-market-dynamics-prevalence-pipeline-treatments-key-statistics-key-players-delveinsight Wed, 21 May 2025 15:42:46 +0530 Kanishk Kumar https://blog.rackons.in/peripheral-neuropathic-pain-and-diabetes-a-growing-healthcare-challenge https://blog.rackons.in/peripheral-neuropathic-pain-and-diabetes-a-growing-healthcare-challenge Wed, 21 May 2025 14:35:34 +0530 Kanishk Kumar https://blog.rackons.in/reimagining-respiratory-medicine-what-ats-2025-delivered https://blog.rackons.in/reimagining-respiratory-medicine-what-ats-2025-delivered Wed, 21 May 2025 11:22:33 +0530 Kanishk Kumar https://blog.rackons.in/dermatomyositis-drugs-market-2034-clinical-trials-fda-ema-pmda-approvals-treatment-status-epidemiology-emerging-therapies-market-insights-key-players-by-delveinsight https://blog.rackons.in/dermatomyositis-drugs-market-2034-clinical-trials-fda-ema-pmda-approvals-treatment-status-epidemiology-emerging-therapies-market-insights-key-players-by-delveinsight Tue, 20 May 2025 10:09:39 +0530 Kanishk Kumar https://blog.rackons.in/hyperhidrosis-treatment-market-status-to-2032-clinical-trials-approvals-fda-ema-pmda-drug-status-prevalence-insights-treatment-pipeline-key-statistics-market-players https://blog.rackons.in/hyperhidrosis-treatment-market-status-to-2032-clinical-trials-approvals-fda-ema-pmda-drug-status-prevalence-insights-treatment-pipeline-key-statistics-market-players Mon, 19 May 2025 10:00:41 +0530 Kanishk Kumar https://blog.rackons.in/chronic-plaque-psoriasis-market-to-show-significant-growth-trend-from-2024-to-2034-delveinsight-report-zai-lab-ucb-biopharma-srl-taizhou-mabtech-pharma-sun-pharma-janssen-rd-livzon-pharma https://blog.rackons.in/chronic-plaque-psoriasis-market-to-show-significant-growth-trend-from-2024-to-2034-delveinsight-report-zai-lab-ucb-biopharma-srl-taizhou-mabtech-pharma-sun-pharma-janssen-rd-livzon-pharma Fri, 16 May 2025 10:02:56 +0530 Kanishk Kumar https://blog.rackons.in/onycholysis-market-aims-for-robust-growth-by-2032-key-players-include-pfizer-etc https://blog.rackons.in/onycholysis-market-aims-for-robust-growth-by-2032-key-players-include-pfizer-etc Thu, 15 May 2025 10:19:05 +0530 Kanishk Kumar https://blog.rackons.in/the-impact-of-family-history-on-ascvd-prevalence https://blog.rackons.in/the-impact-of-family-history-on-ascvd-prevalence Wed, 14 May 2025 17:21:42 +0530 Kanishk Kumar https://blog.rackons.in/alopecia-areata-market-expected-to-expand-at-27-cagr-by-2034-insights-by-delveinsight-covering-ema-pmda-fda-approvals-clinical-trials-treatments-prevalence-and-key-players https://blog.rackons.in/alopecia-areata-market-expected-to-expand-at-27-cagr-by-2034-insights-by-delveinsight-covering-ema-pmda-fda-approvals-clinical-trials-treatments-prevalence-and-key-players Wed, 14 May 2025 09:47:05 +0530 Kanishk Kumar https://blog.rackons.in/rd-trends-in-mocod-a-what-biopharma-needs-to-know https://blog.rackons.in/rd-trends-in-mocod-a-what-biopharma-needs-to-know Tue, 13 May 2025 11:18:07 +0530 Kanishk Kumar https://blog.rackons.in/pemphigus-vulgaris-drug-market-outlook-2034-approvals-clinical-status-epidemiology-nda-status-revenue-mechanism-of-action-leading-therapies-and-key-players-delveinsight-report https://blog.rackons.in/pemphigus-vulgaris-drug-market-outlook-2034-approvals-clinical-status-epidemiology-nda-status-revenue-mechanism-of-action-leading-therapies-and-key-players-delveinsight-report Tue, 13 May 2025 09:27:47 +0530 Kanishk Kumar https://blog.rackons.in/cutting-edge-lung-cancer-research-spotlighted-at-elcc-2025 https://blog.rackons.in/cutting-edge-lung-cancer-research-spotlighted-at-elcc-2025 Mon, 12 May 2025 20:00:20 +0530 Kanishk Kumar https://blog.rackons.in/ai-and-the-mind-transforming-mental-wellness-strategies https://blog.rackons.in/ai-and-the-mind-transforming-mental-wellness-strategies Sun, 11 May 2025 22:09:44 +0530 Kanishk Kumar https://blog.rackons.in/aan-2025-late-breaking-science-whats-transforming-the-field https://blog.rackons.in/aan-2025-late-breaking-science-whats-transforming-the-field Sun, 11 May 2025 19:42:25 +0530 Kanishk Kumar https://blog.rackons.in/healthcare-at-a-crossroads-managing-the-fallout-of-new-us-tariffs https://blog.rackons.in/healthcare-at-a-crossroads-managing-the-fallout-of-new-us-tariffs Sun, 11 May 2025 17:51:06 +0530 Kanishk Kumar https://blog.rackons.in/according-to-delveinsight-the-burn-injury-market-is-expected-to-experience-significant-growth-by-2034-key-players-cumberland-pharmaceuticals-janssen-rd-cephalon https://blog.rackons.in/according-to-delveinsight-the-burn-injury-market-is-expected-to-experience-significant-growth-by-2034-key-players-cumberland-pharmaceuticals-janssen-rd-cephalon Sun, 11 May 2025 12:16:58 +0530 Kanishk Kumar https://blog.rackons.in/complete-market-visibility https://blog.rackons.in/complete-market-visibility Sat, 10 May 2025 08:35:48 +0530 Kanishk Kumar